Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients

No abstract is available for this paper.

• Publication year

  1992

• Venue

  European Journal of Clinical Investigation

• Publication date

  1992-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2362.1992.tb01496.xPMID 1516598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonparametric Statistics for the Behavioral Sciences

  2022cited by this paper
• Influence of protein intake on renal hemodynamics and plasma hormone concentrations in normal subjects.

  2009cited by this paper
• Octreotide stimulates insulin-like growth factor binding protein-1 (IGFBP-1) levels in acromegaly.

  1991cited by this paper
• Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.

  1991cited by this paper
• Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

  1991cited by this paper
• Acute Effects of a Somatostatin Analogue on Kidney Function in Type 1 Diabetic Patients

  1990cited by this paper
• Clinical applications of somatostatin analogs.

  1990cited by this paper
• Prediction of Clinical Diabetic Nephropathy in IDDM Patients: Alternatives to Microalbuminuria?

  1990cited by this paper
• Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.

  1990cited by this paper
• Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis.

  1990cited by this paper
• The renal response to an acute protein load in man: clinical perspective.

  1990cited by this paper
• Glucagon secretion is essential for aminoacid-induced hyperfiltration in man.

  1990cited by this paper
• Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats.

  1989cited by this paper
• Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects.

  1989cited by this paper
• Kidney Hemodynamics After Ketone Body and Amino Acid Infusion in Normal and IDDM Subjects

  1989cited by this paper
• Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats

  1989cited by this paper
• Early glomerular hyperfiltration and the development of late nephropathy in Type 1 (insulin-dependent) diabetes mellitus

  1988cited by this paper
• The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors.

  1988cited by this paper
• Glucagon and prostaglandins are mediators of amino acid-induced rise in renal hemodynamics.

  1988cited by this paper
• ACROMEGALY

  1987cited by this paper
• Declining Incidence of Persistent Proteinuria in Type I (Insulin-Dependent) Diabetic Patients in Denmark

  1987cited by this paper
• Renal reserve filtration capacity in patients with type 1 (insulin-dependent) diabetes mellitus.

  1987cited by this paper
• Renal hemodynamic changes in humans: response to protein loading in normal and diseased kidneys.

  1987cited by this paper
• Suppression of growth hormone and somatomedin C by long-acting somatostatin analog SMS 201-995 in type I diabetes mellitus.

  1987cited by this paper
• Effect of amino acid infusion on renal hemodynamics in humans.

  1986cited by this paper
• Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease.

  1986cited by this paper
• Renal hemodynamics during separate and combined infusion of amino acids and dopamine.

  1986cited by this paper
• Human renal response to meat meal.

  1986cited by this paper
• The kidney in diabetes: significance of the early abnormalities.

  1986cited by this paper
• The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.

  1986cited by this paper
• EFFECTS OF SOMATOSTATIN ANALOGUE SMS 201–995 IN NORMAL MAN

  1986cited by this paper
• The effect of low-dose dopamine on renal haemodynamics in patients with type 1 (insulin-dependent) diabetes does not differ from normal individuals

  1986cited by this paper
• Short-term protein loading in diabetics with a ten-year duration of disease.

  1986cited by this paper
• Mechanisms controlling renal hemodynamics and electrolyte excretion during amino acids.

  1986cited by this paper
• Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy.

  1986cited by this paper
• Renal hemodynamic changes in humans. Response to protein loading in normal and diseased kidneys.

  1986cited by this paper
• The influence of a Long-acting samatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis

  1986cited by this paper
• Blood Pressure Changes and Renal Function in Incipient and Overt Diabetic Nephropathy

  1985cited by this paper
• Postprandial regulation of renal hemodynamics: role of pancreatic glucagon.

  1985cited by this paper
• Clinical applications of somatostatin analogs.

  1985cited by this paper
• Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: deficient production of this hormone in hepatic failure causes hepatorenal syndrome.

  1984cited by this paper
• Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis.

  1982cited by this paper
• Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.

  1982cited by this paper
• The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

  1982cited by this paper
• Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation.

  1981cited by this paper
• Kidney function and size in normal subjects before and during growth hormone administration for one week

  1981cited by this paper
• Effects of dopamine on canine intrarenal blood flow distribution during hemorrhage.

  1979cited by this paper
• A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow.

  1977cited by this paper
• The effect of short-term glucagon infusion on kidney function in normal man

  1977cited by this paper
• The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.

  1975cited by this paper
• Superficial and juxtamedullary nephron function during saline loading in the dog.

  1974cited by this paper
• EXTRACELLULAR FLUID VOLUME AND RENAL FUNCTION IN PITUITARY INSUFFICIENCY AND ACROMEGALY.

  1964cited by this paper
• Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man.

  1962cited by this paper
• Glomerular filtration rate and renal plasma flow in acromegaly.

  1956cited by this paper
• MULTIPLE RANGE AND MULTIPLE F TESTS

  1955cited by this paper

• Reduction of polycystic kidney and liver volumes in a patient with tolvaptan-resistant autosomal dominant polycystic kidney disease and acromegaly during lanreotide therapy

  2025cites this paper
• Prolactin and Other Pituitary Disorders in Kidney Disease.

  2021cites this paper
• INSULIN-LIKE GROWTH FACTOR I AND ALTERED RENAL HAEMODYNAMICS IN GROWTH HORMONE DEFICIENCY , ACROMEGALY AND DIABETES MELLITUS

  2019cites this paper
• Treatable glomerular hyperfiltration in patients with active acromegaly.

  2016cites this paper
• A systematic review of glomerular hyperfiltration assessment and definition in the medical literature.

  2015cites this paper
• Current Directions in Insulin-Like Growth Factor Research

  2013cites this paper
• Impact of growth hormone hypersecretion on the adult human kidney.

  2011cites this paper
• Evaluation of the Impact of Treatment on Endothelial Function and Cardiac Performance in Acromegaly

  2010cites this paper
• Pegvisomant: current and potential novel therapeutic applications

  2009cites this paper
• Kidney protection during peptide receptor radionuclide therapy (PRRT)

  2009cites this paper
• Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients

  2009cites this paper
• Identification, treatment and management of cardiovascular risks in patients with acromegaly

  2008cites this paper
• Manipulation of the growth hormone IGF-I axis in type one diabetes : insight into physiological mechanisms and potential strategies for therapeutic intervention

  2008cites this paper
• Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney

  2007cites this paper
• Chapter 73 – Nonadrenal Endocrine Hypertension

  2007cites this paper
• Growth hormone distribution kinetics are markedly reduced in adults with growth hormone deficiency

  2007cites this paper
• Endothelial Dysfunction in Patients with Acromegaly

  2005cites this paper
• The Kidney and the Insulin-Like Growth Factor System in Health and Disease

  2004cites this paper
• Cardiovascular function in acromegaly.

  2003cites this paper
• Altered GH elimination kinetics in type 1 diabetes mellitus can explain the elevation in circulating levels: bicompartmental approach.

  2002cites this paper
• Renal hemodynamic effects of somatostatin are not related to inhibition of endogenous insulin release.

  2002cites this paper
• Growth hormone replacement does not elevate albuminuria in GH-deficient adults

  2002cites this paper
• Effects of a long‐acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: A randomized, double‐blind, controlled trial

  2001cites this paper
• Endothelial dysfunction in endocrine disease.

  2001cites this paper
• Exercise-induced microalbuminuria in patients with active acromegaly: acute effects of slow-release lanreotide, a long-acting somatostatin analog.

  2000cites this paper
• Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency

  1999cites this paper
• An open, phase III study of lanreotide (Somatuline PR) in the treatment of acromegaly.

  1999cites this paper
• Insulin-like growth factor system and the kidney: physiology, pathophysiology, and therapeutic implications.

  1998cites this paper
• Contribution of Growth Hormone and IGF-I to Early Diabetic Nephropathy in Type 1 Diabetes

  1998cites this paper
• Heterogeneous haemodynamics in acromegaly: evidence of endothelial dysfunction? *

  1998cites this paper
• Hormonal influence on renal function with particular reference to diabetes mellitus

  1998cites this paper
• Effect of Long-Acting Somatostatin Analog (Somatulin) on Renal Hyperfiltration in Patients With IDDM

  1997influential citation
• Evidence for octreotide subcutaneously in the treatment of acromegaly.

  1997cites this paper
• Growth hormone, the insulin-like growth factor system, and the kidney.

  1996cites this paper
• Assessment of growth hormone (GH) plasma clearance rate, half-life, and volume of distribution in acromegalic patients: the combined GH-octreotide infusion.

  1995cites this paper
• CHAPTER 8 INSULIN-LIKE GROWTH FACTOR I AND ALTERED RENAL HAEMODYNAMICS IN GROWTH HORMONE DEFICIENCY, ACROMEGALY AND DIABETES MELLITUS

  1994influential citation
• Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency.

  1993cites this paper
• Effects of growth hormone and IGF-I on glomerular ultrafiltration in growth hormone-deficient rats.

  1993cites this paper
• The physiology and pathophysiology of IGF-I in the kidney.

  1993cites this paper
• Contributory roles of circulatory glucagon and growth hormone to increased renal haemodynamics in type 1 (insulin-dependent) diabetes mellitus.

  1993cites this paper
• Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion.

  1993cites this paper
• Renal reserve filtration capacity in growth hormone deficient subjects

  1992cites this paper
• Phase Treatment of III Study of Lanreoti Acromegaly de ( Somatuline PR ® ) in

  year unknowncites this paper